What is the primary objective of FDA 21 CFR Part 11?

The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the FDA considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper. As stated in §11.1(a), it ensures authenticity, integrity, and, where appropriate, confidentiality of records created, modified, maintained, archived, retrieved, or transmitted under predicate rules. Controls in Subparts B (§§11.10 closed systems, §11.30 open systems) and C (§§11.50–11.300 signatures) support non-repudiation and inspection readiness per §11.1(e).

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

FDA 21 CFR Part 11 applies to any organization using electronic records or signatures in lieu of paper for predicate rule requirements or relying on them for regulated activities. Per §11.1(b), it covers records under FDA regulations (e.g., CGMP Parts 211/820) or electronic submissions accepted per docket 92S-0251. Exclusions include paper records transmitted electronically (§11.1(b)) and specific food parts (§11.1(f)–(p)). Life sciences firms (pharma, devices, biologics) must comply when electronic records replace paper or are relied upon, even if paper exists.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal controls, validation, SOPs, and inspection readiness (§11.1(e)). FDA's 2003 guidance emphasizes risk-based approaches with documented evidence of system fitness, but enforcement occurs via FDA inspections, not mandated external audits. Organizations must maintain records readily available for agency review (§11.10(b)).

How often should an assessment for FDA 21 CFR Part 11 be performed?

FDA 21 CFR Part 11 does not prescribe a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based validation lifecycles. Per §11.10(k), controls over documentation require revision and change procedures. FDA's 2003 guidance supports ongoing fitness-for-use checks tied to predicate rules, with reassessments triggered by system changes, upgrades, or inspection findings. Industry practice includes annual reviews for high-risk systems.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 results in FDA enforcement actions including Form 483 observations, warning letters, product holds, import alerts, civil money penalties, and potential injunctions. Predicate rule violations remain fully enforceable (2003 guidance), leading to recalls or market restrictions. Examples include data integrity failures in audits causing batch rejections or submission invalidation.

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

FDA 21 CFR Part 11 is not explicitly mapped to other frameworks in its text or 2003 guidance; mappings require organizational risk assessments. Core controls (access, audit trails, signatures) align conceptually with data integrity principles like ALCOA+, but FDA emphasizes narrow scope and predicate rules without cross-references.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions. Per 2003 guidance, document in SOPs whether electronic records replace paper, are relied upon for regulated activities, or involve binding signatures (§11.1(b), §11.100(c)). Classify systems as closed (§11.3(b)(4)) or open (§11.3(b)(9)).

What is the primary objective of APRA CPS 234?

APRA CPS 234 requires regulated entities to maintain an information security capability commensurate with vulnerabilities and threats to minimise the likelihood and impact of incidents on the confidentiality, integrity or availability of information assets. This explicitly includes assets managed by related parties or third parties (paragraphs 15-16), enabling continued sound operation of the entity.

Who is legally or professionally required to comply with APRA CPS 234?

APRA CPS 234 applies to all APRA-regulated entities, including authorised deposit-taking institutions (ADIs), general insurers, life companies, private health insurers, and RSE licensees. For Heads of groups, it must be applied group-wide, including non-regulated entities (paragraphs 2, 4). Foreign ADIs and similar entities comply for Australian branch operations only (paragraph 3).

Does APRA CPS 234 require an external audit or third-party certification?

APRA CPS 234 does not mandate external audits or third-party certification but requires internal audit to review the design and operating effectiveness of information security controls, including those maintained by related parties and third parties (paragraphs 32-34). Internal audit must assess third-party assurance if relying on it for material-impact assets and ensure personnel are appropriately skilled (paragraphs 33-34).

How often should an assessment for APRA CPS 234 be performed?

APRA CPS 234 requires the testing program to be reviewed at least annually or upon material change to information assets or the business environment (paragraph 31). Systematic testing of control effectiveness must occur with frequency commensurate with changes in vulnerabilities/threats, asset criticality/sensitivity, and incident consequences (paragraph 27); information security response plans must be reviewed and tested annually (paragraph 26).

What are the consequences of non-compliance with APRA CPS 234?

Non-compliance with APRA CPS 234 exposes entities to APRA's prudential enforcement powers, including directions, remediation requirements, increased supervision, and potential penalties under enabling Acts like the Banking Act 1959. Entities must notify APRA within 72 hours of material incidents (paragraph 35) or 10 business days of material control weaknesses not remediable timely (paragraph 36), triggering supervisory scrutiny.

Can APRA CPS 234 be mapped to other international frameworks?

Yes, APRA CPS 234's outcomes-based requirements for governance, controls, testing, and third-party management can be mapped to frameworks like ISO 27001 and NIST Cybersecurity Framework. It aligns conceptually with CPS 220 Risk Management but remains distinct in Board accountability (paragraph 13) and notification timelines (paragraphs 35-36), enabling proportional implementation via these mappings.

What is the first step to begin implementing APRA CPS 234?

The Board must exercise ultimate responsibility by approving and overseeing an information security capability commensurate with threats, starting with defining roles and responsibilities for the Board, senior management, and others (paragraphs 13-14). This establishes governance as the foundation before asset classification (paragraph 20) and policy framework development (paragraphs 18-19).

Standards Comparison

FDA 21 CFR Part 11 vs APRA CPS 234

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

APRA CPS 234

Mandatory

2019

Australian prudential standard for information security resilience

Quick Verdict

FDA 21 CFR Part 11 ensures electronic records/signatures trust for US life sciences, while APRA CPS 234 mandates cyber resilience for Australian finance. Pharma adopts Part 11 for FDA compliance; banks use CPS 234 to meet prudential oversight and avoid penalties.

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11: Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

Medium

Implementation Time

18-24 months

Key Features

Establishes equivalence of electronic records to paper
Mandates secure, time-stamped audit trails
Requires unique, non-repudiable electronic signatures
Enforces closed/open system access controls
Demands risk-based system validation

Information Security

APRA CPS 234

APRA Prudential Standard CPS 234 Information Security

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Board ultimate responsibility for information security
72-hour APRA notification for material incidents
Third-party asset management requirements
Systematic independent control testing program
Asset classification by criticality and sensitivity

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The risk-based approach narrows scope to relied-upon electronic records, with enforcement discretion on some elements like validation.

Key Components

**Subpart AScope, definitions (closed/open systems).
**Subpart BControls for records (audit trails, access, validation; §11.10/11.30).
**Subpart CSignature requirements (uniqueness, linking, multi-component; §§11.50-11.300). Core principles include data integrity (ALCOA+), non-repudiation. No formal certification; compliance via inspection.

Why Organizations Use It

Ensures regulatory acceptance of digital records, mitigates enforcement risks (warnings, holds), supports data integrity for quality decisions. Benefits: efficiency, inspection readiness, stakeholder trust in pharma/biotech/devices.

Implementation Overview

Risk-based CSV (GAMP5): scope records, validate systems (IQ/OQ/PQ), implement controls, train users. Applies to life sciences; phased (6-24 months), ongoing via change control, audits.

APRA CPS 234 Details

What It Is

APRA Prudential Standard CPS 234 (Information Security) is a binding regulation issued by the Australian Prudential Regulation Authority for regulated financial entities. Effective from 1 July 2019, it mandates maintaining information security capabilities commensurate with threats to ensure resilience against incidents impacting confidentiality, integrity, or availability (CIA) of information assets, including those managed by third parties.

Key Components

**Governance and accountabilityBoard ultimate responsibility, defined roles.
**Risk managementAsset classification by criticality/sensitivity, commensurate controls.
**Testing and assuranceSystematic testing, internal audit reviews.
**Incident response72-hour APRA notification for material incidents, annual plan testing. Built on risk-based, assurance-driven principles; no fixed control count, focuses on outcomes.

Why Organizations Use It

Mandatory for APRA-regulated entities (banks, insurers, super funds); reduces cyber risks, ensures operational continuity, builds stakeholder trust. Enhances prudential compliance, avoids penalties, strengthens third-party oversight.

Implementation Overview

Phased approach: gap analysis, policy framework, asset inventory, controls/testing, third-party assessments. Applies to all sizes in Australian financial sector; requires ongoing assurance, no formal certification but APRA supervision.

Key Differences

Aspect	FDA 21 CFR Part 11	APRA CPS 234
Scope	Electronic records/signatures equivalence to paper	Information security capability and cyber resilience
Industry	US life sciences, pharma, medical devices	Australian financial services (banks, insurers)
Nature	Mandatory US FDA regulation with enforcement discretion	Mandatory prudential standard with strict notifications
Testing	Risk-based system validation, audit trails	Systematic independent control testing annually
Penalties	Warning letters, product holds, enforcement actions	Supervisory directions, penalties, license restrictions

Scope

FDA 21 CFR Part 11

Electronic records/signatures equivalence to paper

APRA CPS 234

Information security capability and cyber resilience

Industry

FDA 21 CFR Part 11

US life sciences, pharma, medical devices

APRA CPS 234

Australian financial services (banks, insurers)

Nature

FDA 21 CFR Part 11

Mandatory US FDA regulation with enforcement discretion

APRA CPS 234

Mandatory prudential standard with strict notifications

Testing

FDA 21 CFR Part 11

Risk-based system validation, audit trails

APRA CPS 234

Systematic independent control testing annually

Penalties

FDA 21 CFR Part 11

Warning letters, product holds, enforcement actions

APRA CPS 234

Supervisory directions, penalties, license restrictions

Frequently Asked Questions

Common questions about FDA 21 CFR Part 11 and APRA CPS 234

FDA 21 CFR Part 11 FAQ

APRA CPS 234 FAQ

You Might also be Interested in These Articles...

Why Default Microsoft 365 Settings Fail Cyber Essentials: A 2026 Audit-Ready Configuration Guide for UK SMEs

Uncover why out-of-the-box Microsoft 365 fails Cyber Essentials v3.3 assessments in 2026. Step-by-step hardening for Entra ID, Intune, MFA and 14-day patching t

CMMC Scoping Mastery for Defense Supply Chains: Enclave Mapping, Subcontractor Flow-Down, and CUI Inventory Blueprint

Master CMMC scoping for DIB: delineate FCI/CUI boundaries, segment enclaves, manage subcontractor flow-down. Prevent 80% assessment failures with SSP templates,

Top 10 SOC 2 Audit Pitfalls and Fixes: Real Auditor Red Flags from Type 2 Fieldwork with Evidence Checklists

Discover 10 common SOC 2 Type 2 audit pitfalls like evidence gaps, scope creep, vendor oversights. Get Fail/Pass visuals, client stories, checklists for 95% fir

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how FDA 21 CFR Part 11 and APRA CPS 234 compare against other standards

Other FDA 21 CFR Part 11 Comparisons

Other APRA CPS 234 Comparisons

What It Is

Key Components

**Subpart AScope, definitions (closed/open systems).

**Subpart BControls for records (audit trails, access, validation; §11.10/11.30).

**Subpart CSignature requirements (uniqueness, linking, multi-component; §§11.50-11.300). Core principles include data integrity (ALCOA+), non-repudiation. No formal certification; compliance via inspection.

What It Is

Key Components

**Governance and accountabilityBoard ultimate responsibility, defined roles.

**Risk managementAsset classification by criticality/sensitivity, commensurate controls.

**Testing and assuranceSystematic testing, internal audit reviews.

**Incident response72-hour APRA notification for material incidents, annual plan testing. Built on risk-based, assurance-driven principles; no fixed control count, focuses on outcomes.

Aspect

FDA 21 CFR Part 11

APRA CPS 234

Scope

Electronic records/signatures equivalence to paper

Information security capability and cyber resilience

Industry

US life sciences, pharma, medical devices

Australian financial services (banks, insurers)

Nature

Mandatory US FDA regulation with enforcement discretion

Mandatory prudential standard with strict notifications

Testing

Risk-based system validation, audit trails

Systematic independent control testing annually

Penalties

Warning letters, product holds, enforcement actions

Supervisory directions, penalties, license restrictions